Literature DB >> 30980856

Motivation to eat and not to eat - The psycho-biological conflict in anorexia nervosa.

Guido K W Frank1, Marisa C DeGuzman2, Megan E Shott3.   

Abstract

Anorexia nervosa is a severe psychiatric illness with high mortality. Brain imaging research has indicated altered reward circuits in the disorder. Here we propose a disease model for anorexia nervosa, supported by recent studies, that integrates psychological and biological factors. In that model, we propose that there is a conflict between the conscious motivation to restrict food, and a body-homeostasis driven motivation to approach food in response to weight loss. These opposing motivations trigger anxiety, which maintains the vicious cycle of ongoing energy restriction and weight loss.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anorexia nervosa; Anxiety; Brain; Conflict; Motivation

Year:  2019        PMID: 30980856      PMCID: PMC6520121          DOI: 10.1016/j.physbeh.2019.04.007

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  96 in total

Review 1.  Taste, olfactory and food texture reward processing in the brain and obesity.

Authors:  E T Rolls
Journal:  Int J Obes (Lond)       Date:  2010-08-03       Impact factor: 5.095

Review 2.  Metabolic sensing in brain dopamine systems.

Authors:  Ivan E de Araujo; Xueying Ren; Jozélia G Ferreira
Journal:  Results Probl Cell Differ       Date:  2010

3.  Dopamine-mediated reinforcement learning signals in the striatum and ventromedial prefrontal cortex underlie value-based choices.

Authors:  Gerhard Jocham; Tilmann A Klein; Markus Ullsperger
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 4.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

5.  Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.

Authors:  Guido K Frank; Ursula F Bailer; Shannan E Henry; Wayne Drevets; Carolyn C Meltzer; Julie C Price; Chester A Mathis; Angela Wagner; Jessica Hoge; Scott Ziolko; Nicole Barbarich-Marsteller; Lisa Weissfeld; Walter H Kaye
Journal:  Biol Psychiatry       Date:  2005-06-29       Impact factor: 13.382

6.  Mortality in anorexia nervosa.

Authors:  P F Sullivan
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

7.  The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa.

Authors:  Guido K W Frank; Megan E Shott; Jennifer O Hagman; Marissa A Schiel; Marisa C DeGuzman; Brogan Rossi
Journal:  Int J Eat Disord       Date:  2017-03-23       Impact factor: 4.861

8.  Underweight rats have enhanced dopamine release and blunted acetylcholine response in the nucleus accumbens while bingeing on sucrose.

Authors:  N M Avena; P Rada; B G Hoebel
Journal:  Neuroscience       Date:  2008-08-22       Impact factor: 3.590

Review 9.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

Review 10.  A ventral tegmental CRF-glutamate-dopamine interaction in addiction.

Authors:  Roy A Wise; Marisela Morales
Journal:  Brain Res       Date:  2009-10-01       Impact factor: 3.252

View more
  15 in total

1.  Dopaminergic activity and exercise behavior in anorexia nervosa.

Authors:  Sasha Gorrell; Anne G E Collins; Daniel Le Grange; Tony T Yang
Journal:  OBM Neurobiol       Date:  2020-03-23

Review 2.  Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders.

Authors:  Pamela K Keel; Lindsay P Bodell; K Jean Forney; Jonathan Appelbaum; Diana Williams
Journal:  Physiol Behav       Date:  2019-05-30

3.  Neuroimaging of hypothalamic mechanisms related to glucose metabolism in anorexia nervosa and obesity.

Authors:  Joe J Simon; Marion A Stopyra; Esther Mönning; Sebastian Sailer; Nora Lavandier; Lars P Kihm; Martin Bendszus; Hubert Preissl; Wolfgang Herzog; Hans-Christoph Friederich
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 4.  Neuroimaging and eating disorders.

Authors:  Guido K W Frank
Journal:  Curr Opin Psychiatry       Date:  2019-11       Impact factor: 4.741

5.  The Role of Dopamine in Contributing to Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa.

Authors:  Sasha Gorrell
Journal:  Biol Psychiatry       Date:  2021-12-15       Impact factor: 12.810

6.  Neurosurgery and neuromodulation for anorexia nervosa in the 21st century: a systematic review of treatment outcomes.

Authors:  Stuart B Murray; Michael Strober; Reza Tadayonnejad; Ausaf A Bari; Jamie D Feusner
Journal:  Eat Disord       Date:  2020-09-29       Impact factor: 3.222

7.  Eating Disorders: An Evolutionary Psychoneuroimmunological Approach.

Authors:  Markus J Rantala; Severi Luoto; Tatjana Krama; Indrikis Krams
Journal:  Front Psychol       Date:  2019-10-29

8.  Vulnerable and Resilient Phenotypes in a Mouse Model of Anorexia Nervosa.

Authors:  Jeff A Beeler; Devry Mourra; Roseanna M Zanca; Abigail Kalmbach; Celia Gellman; Benjamin Y Klein; Rebecca Ravenelle; Peter Serrano; Holly Moore; Stephen Rayport; Susana Mingote; Nesha S Burghardt
Journal:  Biol Psychiatry       Date:  2020-07-16       Impact factor: 13.382

Review 9.  Pharmacotherapeutic strategies for the treatment of anorexia nervosa - too much for one drug?

Authors:  Guido K W Frank
Journal:  Expert Opin Pharmacother       Date:  2020-04-13       Impact factor: 3.889

10.  Emotional-Behavioral Regulation, Temperament and Parent-Child Interactions Are Associated with Dopamine Transporter Allelic Polymorphism in Early Childhood: A Pilot Study.

Authors:  Silvia Cimino; Eleonora Marzilli; Mimma Tafà; Luca Cerniglia
Journal:  Int J Environ Res Public Health       Date:  2020-11-18       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.